China SXT Pharmaceuticals, Inc. (SXTC) Margin Analysis - Discounting Cash Flows
SXTC
China SXT Pharmaceuticals, Inc.
SXTC (NASDAQ)

Years and Quarters

Years

Years

The number of historical years used to render the annual chart and tables.

Quarters

Quarters

The number of historical quarters used to render the quarterly chart and tables.

Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (example: Net Income Margin = Net Income / Revenue).

This analysis provides annual and quarterly sections for reporting key financial margins.

Annual Section

The annual section uses annual data to calculate margins and growth rates.

Monetary values in USD

amounts except #

LTM
Mar 15
2025
Mar 31
2024
Mar 31
2023
Mar 31
2022
Mar 31
Revenue 1.74 1.74 1.93 1.97 2.6
Revenue Growth Rate 0% -9.73% -2.19% -24.23% -45.53%
Cost of Revenue 1.37 1.37 1.37 1.55 1.35
Gross Profit 0.367 0.367 0.554 0.426 1.25
Gross Margin 21.11% 21.11% 28.73% 21.62% 48.1%
Operating Income -2.68 -2.68 -2.52 -5.61 -5.19
Operating Margin -154% -154% -130.4% -284.4% -199.4%
Net Income -3.3 -3.3 -3.1 -5.93 -5.74
Net Margin -189.8% -189.8% -160.7% -301% -220.4%

Monetary values in USD

amounts except #

LTM
Mar 15
2025
Mar 31
2024
Mar 31
2023
Mar 31
2022
Mar 31
Revenue 1.74 1.74 1.93 1.97 2.6
Cash from Operating Activities -2.35 -2.35 -1.93 -0.081 0.268
Cash from Operating Activities Margin -134.7% -134.7% -99.98% -4.1% 10.31%
Free Cash Flow -2.35 -2.35 -1.94 -0.151 0.206
Free Cash Flow Margin -134.8% -134.8% -100.3% -7.68% 7.91%
Depreciation and Amortization 0.603 0.082 0.203 0.25 0.32
Depreciation and Amortization Margin 34.64% 4.73% 10.54% 12.69% 12.3%
Capital Expenditure -0.002 -0.002 -0.007 -0.071 -0.062
Capital Expenditure Margin -0.116% -0.116% -0.366% -3.58% -2.4%

Annual Chart

Monetary values in USD

Quarterly Section

The quarterly section uses quarterly data to calculate margins and growth rates.

Monetary values in USD

amounts except #

2025 (Q4)
Mar 31
2025 (Q3)
Dec 31
2025 (Q2)
Sep 30
2025 (Q1)
Jun 30
2024 (Q4)
Mar 31
2024 (Q3)
Dec 31
2024 (Q2)
Sep 30
2024 (Q1)
Jun 30
2023 (Q4)
Mar 31
Revenue 0.456 0.456 0.415 0.415 0.494 0.494
Revenue Growth Rate 0% 9.88% 0% -16.12% 0%
Cost of Revenue 0.339 0.339 0.347 0.347 0.362 0.362
Gross Profit 0.116 0.116 0.067 0.067 0.133 0.133
Gross Margin 25.53% 25.53% 16.25% 16.25% 26.86% 26.86%
Operating Income -1.02 -1.02 -0.319 -0.319 3.42 3.42
Operating Margin -224.1% -224.1% -76.95% -76.95% 691% 691%
Net Income -1.25 -1.25 -0.401 -0.401 3.3 3.3
Net Margin -274.4% -274.4% -96.75% -96.75% 667.2% 667.2%

Monetary values in USD

amounts except #

2025 (Q4)
Mar 31
2025 (Q3)
Dec 31
2025 (Q2)
Sep 30
2025 (Q1)
Jun 30
2024 (Q4)
Mar 31
2024 (Q3)
Dec 31
2024 (Q2)
Sep 30
2024 (Q1)
Jun 30
2023 (Q4)
Mar 31
Revenue 0.456 0.456 0.415 0.415 0.494 0.494
Cash from Operating Activities -0.494 -0.494 -0.679 -0.679 -0.674 -0.674
Cash from Operating Activities Margin -108.4% -108.4% -163.6% -163.6% -136.4% -136.4%
Free Cash Flow -0.495 -0.495 -0.679 -0.679 -0.678 -0.678
Free Cash Flow Margin -108.6% -108.6% -163.6% -163.6% -137.1% -137.1%
Depreciation and Amortization 0.223 0.223 0.078 0.078 0.09 0.09
Depreciation and Amortization Margin 48.95% 48.95% 18.93% 18.93% 18.26% 18.26%
Capital Expenditure -0.001 -0.001 0 0 -0.004 -0.004
Capital Expenditure Margin -0.222% -0.222% 0% 0% -0.714% -0.714%

Quarterly Chart

Monetary values in USD

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program